Cardiac Event Clinical Trials

2 recruiting

Cardiac Event Trials at a Glance

10 actively recruiting trials for cardiac event are listed on ClinicalTrialsFinder across 6 cities in 11 countries. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Beijing, Foggia, and Hamilton. Lead sponsors running cardiac event studies include Azienda Ospedaliero, Universitaria Ospedali Riuniti, China National Center for Cardiovascular Diseases, and Aliya Hisam.

Browse cardiac event trials by phase

Treatments under study

About Cardiac Event Clinical Trials

Looking for clinical trials for Cardiac Event? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Cardiac Event trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Cardiac Event clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 110 of 10 trials

Recruiting
Phase 4

Major Adverse Cardiovascular Events (MACE) in Rheumatoid Arthritis Patient With Moderate to Severe Disease Activity Treated With Tofacitinib and Statins vs TNF Inhibitors: TOFSTAT CLINICAL TRIAL

Rheumatoid ArthritisMajor Adverse Cardiac Events
Shaikh Zayed Hospital, Lahore120 enrolled1 locationNCT07554820
Recruiting
Not Applicable

Impact of Assessment and Management of Comorbidities in Internal Medicine on Cardiovascular Risk

Major Adverse Cardiac EventsAdverse Cardiac Event
University Hospital, Montpellier70 enrolled1 locationNCT06204549
Recruiting

TTE Improves Clinical Management of Stable Chest Pain

Stable Angina PectorisCoronary Artery DiseaseMajor Adverse Cardiac Events+2 more
Tianjin Chest Hospital50,000 enrolled1 locationNCT07063147
Recruiting
Not Applicable

Pericardiotomy in Cardiac Surgery

Atrial FibrillationAtrial FlutterCardiac Events
Population Health Research Institute1,400 enrolled4 locationsNCT06486636
Recruiting
Phase 2

Effect of Xenon on Brain Injury After Aneurysmal Subarachnoid Hemorrhage

Cardiac FailureCerebral InfarctionCerebral Ischemia+3 more
Turku University Hospital160 enrolled7 locationsNCT04696523
Recruiting
Phase 4

Low-dose Versus Standard-dose Rivaroxaban in Elderly Patients With Atrial Fibrillation

Atrial FibrillationStrokeAnticoagulant Adverse Reaction+1 more
China National Center for Cardiovascular Diseases4,374 enrolled1 locationNCT06108414
Recruiting

Maternal and Offspring Outcomes in Pregnant Women With Pre-existing ASCVD

Cardiovascular DiseasesAtherosclerosisPregnancy Complications+2 more
Samsung Medical Center5,461,222 enrolled1 locationNCT06406998
Recruiting

Repaired Tetralogy of Fallot Italian Registry

Tetralogy of FallotCardiac EventCardiac Arrhythmia+1 more
Azienda Ospedaliero, Universitaria Ospedali Riuniti150 enrolled1 locationNCT05288894
Recruiting

Effectiveness of “Mobile health augmented Cardiac rehabilitation” (MCard) on health related quality of life, clinical and behavioral outcomes in post-acute coronary syndrome patients

Mobile Health Augmented Cardiac RehabilitationPost acute coronary syndromeMajor Adverse Cardiac Events
Aliya Hisam160 enrolled1 locationACTRN12619001731189
Recruiting

Yeddung Gauar (Good Heart): Feasibility of an Aboriginal and Torres Strait Islander female Cardiac Rehabilitation program delivered in a non-Indigenous health service.

Medium-high risk of a cardiac eventHeart Attack
Dr Nicole Freene20 enrolled2 locationsACTRN12618000581268